(Q38953104)

7 September 2017

title

Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners (English)

1 reference

7 September 2017

0 references

1

1 reference

7 September 2017

8

Chaisson RE

1 reference

7 September 2017

Blumberg L

2

1 reference

7 September 2017

Churchyard GJ

3

1 reference

7 September 2017

Moloi N

4

1 reference

7 September 2017

Mallory K

5

1 reference

7 September 2017

Clayton T

6

1 reference

7 September 2017

Williams BG

7

1 reference

7 September 2017

Hayes RJ

9

1 reference

7 September 2017

De Cock KM

10

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

American Journal of Respiratory and Critical Care Medicine

7 September 2017

published in

1 reference

7 September 2017

volume

160

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

15-21

1 reference

Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Pulmonary disease from nontuberculous mycobacteria in patients with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Mycobacterium kansasii: A Cause of Treatable Pulmonary Disease Associated with Advanced Human Immunodeficiency Virus (HIV) Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Kansas City AIDS Research Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Clinical Manifestations and Implications of Coinfection with Mycobacterium kansasii and Human Immunodeficiency Virus Type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Mycobacterium kansasii disease in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

Influence of Pulmonary Dust Load on the Development of Experimental Infection by Mycobacterium kansasii

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.1.9812080

10.1164/AJRCCM.160.1.9812080

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference